A case of anaplastic lymphoma kinase-positive large B-cell lymphoma: Aspiration cytology findings
Version of Record online: 1 MAR 2013
Copyright © 2013 Wiley Periodicals, Inc.
Volume 42, Issue 1, pages 69–72, January 2014
How to Cite
Nakatsuka, S.-i., Oku, K., Nagano, T., Kimura, H., Hanamoto, A., Ito, M. and Hashimoto, K. (2014), A case of anaplastic lymphoma kinase-positive large B-cell lymphoma: Aspiration cytology findings. Diagn. Cytopathol., 42: 69–72. doi: 10.1002/dc.22968
- Issue online: 26 DEC 2013
- Version of Record online: 1 MAR 2013
- Manuscript Accepted: 1 JAN 2013
- Manuscript Revised: 26 OCT 2012
- Manuscript Received: 18 MAY 2012
- anaplastic lymphoma kinase;
- large B-cell lymphoma;
- aspiration cytology
Anaplastic lymphoma kinase-positive (ALK+) large B-cell lymphoma (LBCL) is a rare subtype of non-Hodgkin B-cell lymphoma that exhibits a more aggressive clinical course and poorer prognosis than the typical diffuse large B-cell lymphoma. In this study, we report the case of a 67-year-old man with left cervical lymph node swelling. Aspiration cytology revealed many clusters of cohesive, large, and solitary cells. The tumor cells had abundant cytoplasm and large round-to-oval nuclei with prominent nucleoli. The Giemsa staining specimens exhibited amorphous global bodies adjacent to some clusters. Histologically, large tumor cells occupied the lymph nodes in a sinusoidal pattern, and immunohistochemically, these cells were cytokeratin−, CD19−, CD20−, CD79a−, CD3−, CD30−, CD138+, IgG−, IgA+, and ALK+. Chromogenic in situ hybridization revealed restricted immunoglobulin light-chain expression. Fluorescent in situ hybridization demonstrated translocation of the ALK gene. The tumor cells were negative for Epstein–Barr virus and human herpesvirus 8. It is important to differentiate ALK+LBCL from metastatic carcinoma and other lymphoma subtypes with similar histological features to ensure a proper treatment strategy and prediction of prognosis. Diagn. Cytopathol. 2014;42:69–72. © 2013 Wiley Periodicals, Inc.